Literature DB >> 31095097

Brain moderators supporting the relationship between depressive mood and pain.

Adrienne L Adler-Neal1, Nichole M Emerson1, Suzan R Farris1, Youngkyoo Jung2, Robert C Coghill3,4, Fadel Zeidan1,5.   

Abstract

Pain and depressive mood commonly exhibit a comorbid relationship. Yet, the brain mechanisms that moderate the relationship between dysphoric mood and pain remain unknown. An exploratory analysis of functional magnetic resonance imaging, behavioral, and psychophysical data was collected from a previous study in 76 healthy, nondepressed, and pain-free individuals. Participants completed the Beck Depression Inventory-II (BDI), a measure of negative mood/depressive symptomology, and provided pain intensity and pain unpleasantness ratings in response to noxious heat (49°C) during perfusion-based, arterial spin-labeled functional magnetic resonance imaging. Moderation analyses were conducted to determine neural mechanisms involved in facilitating the hypothesized relationship between depressive mood and pain sensitivity. Higher BDI-II scores were positively associated with pain intensity (R = 0.10; P = 0.006) and pain unpleasantness (R = 0.12; P = 0.003) ratings. There was a high correlation between pain intensity and unpleasantness ratings (r = 0.94; P < 0.001); thus, brain moderation analyses were focused on pain intensity ratings. Individuals with higher levels of depressive mood exhibited heightened sensitivity to experimental pain. Greater activation in regions supporting the evaluation of pain (ventrolateral prefrontal cortex; anterior insula) and sensory-discrimination (secondary somatosensory cortex; posterior insula) moderated the relationship between higher BDI-II scores and pain intensity ratings. This study demonstrates that executive-level and sensory-discriminative brain mechanisms play a multimodal role in facilitating the bidirectional relationship between negative mood and pain.

Entities:  

Mesh:

Year:  2019        PMID: 31095097      PMCID: PMC6699932          DOI: 10.1097/j.pain.0000000000001595

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  75 in total

1.  A three-dimensional statistical analysis for CBF activation studies in human brain.

Authors:  K J Worsley; A C Evans; S Marrett; P Neelin
Journal:  J Cereb Blood Flow Metab       Date:  1992-11       Impact factor: 6.200

2.  Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex.

Authors:  Tim V Salomons; Tom Johnstone; Misha-Miroslav Backonja; Alexander J Shackman; Richard J Davidson
Journal:  J Cogn Neurosci       Date:  2007-06       Impact factor: 3.225

3.  Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients.

Authors:  A T Beck; R A Steer; R Ball; W Ranieri
Journal:  J Pers Assess       Date:  1996-12

4.  Pain intensity processing within the human brain: a bilateral, distributed mechanism.

Authors:  R C Coghill; C N Sang; J M Maisog; M J Iadarola
Journal:  J Neurophysiol       Date:  1999-10       Impact factor: 2.714

5.  Anterolateral prefrontal cortex mediates the analgesic effect of expected and perceived control over pain.

Authors:  Katja Wiech; Raffael Kalisch; Nikolaus Weiskopf; Burkhard Pleger; Klaas Enno Stephan; Raymond J Dolan
Journal:  J Neurosci       Date:  2006-11-01       Impact factor: 6.167

6.  Increased sensitivity to heat pain after sad mood induction in female patients with major depression.

Authors:  Janneke Terhaar; Michael Karl Boettger; Christiane Schwier; Gerd Wagner; Anna-Karoline Israel; Karl-Jürgen Bär
Journal:  Eur J Pain       Date:  2009-10-17       Impact factor: 3.931

7.  Effect of Calorie Restriction on Mood, Quality of Life, Sleep, and Sexual Function in Healthy Nonobese Adults: The CALERIE 2 Randomized Clinical Trial.

Authors:  Corby K Martin; Manju Bhapkar; Anastassios G Pittas; Carl F Pieper; Sai Krupa Das; Donald A Williamson; Tammy Scott; Leanne M Redman; Richard Stein; Cheryl H Gilhooly; Tiffany Stewart; Lisa Robinson; Susan B Roberts
Journal:  JAMA Intern Med       Date:  2016-06-01       Impact factor: 21.873

8.  Mood influences supraspinal pain processing separately from attention.

Authors:  Chantal Villemure; M Catherine Bushnell
Journal:  J Neurosci       Date:  2009-01-21       Impact factor: 6.167

9.  Effects of odors on pain perception: deciphering the roles of emotion and attention.

Authors:  Chantal Villemure; Burton M Slotnick; M Catherine Bushnell
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

10.  Orthogonalization of regressors in FMRI models.

Authors:  Jeanette A Mumford; Jean-Baptiste Poline; Russell A Poldrack
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

View more
  4 in total

1.  Individual differences in pain sensitivity in drug-naive patients with major depressive disorder: an fMRI study.

Authors:  Qianmei Hou; Chen Wang; Changyue Hou; Juan Tan; Shaoyue He; Lei Tang; Na Yong; Xianghong Ding; Guohui Jiang; Jixin Liu; Xiaoming Wang
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

2.  Neural correlates of co-occurring pain and depression: an activation-likelihood estimation (ALE) meta-analysis and systematic review.

Authors:  Carmen Jiamin Zheng; Sarah Van Drunen; Natalia Egorova-Brumley
Journal:  Transl Psychiatry       Date:  2022-05-11       Impact factor: 7.989

3.  Somatic pain associated with initiation of interferon-alpha (IFN-α) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study.

Authors:  Chih Ying Lin; Ta-Wei Guu; Hsueh-Chou Lai; Cheng-Yuan Peng; Jill Yi-Ju Chiang; Hui-Ting Chen; Tsai-Chung Li; Shing-Yu Yang; Kuan-Pin Su; Jane Pei-Chen Chang
Journal:  Brain Behav Immun Health       Date:  2020-01-03

4.  The Effects of Mindfulness-Based Stress Reduction on Trauma in Victims of Gun Violence: a Pilot Study.

Authors:  Lora Khatib; Gabriel Riegner; Jon G Dean; Valeria Oliva; Gael Cruanes; Beth A Mulligan; Fadel Zeidan
Journal:  Mindfulness (N Y)       Date:  2022-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.